Cheryl A. Madsen
Algemeen Adviseur bij VIRACTA THERAPEUTICS, INC.
Profiel
Cheryl A.
Madsen is currently the Senior Vice President-Regulatory Affairs at Viracta Therapeutics, Inc. She previously worked as the Senior Director at Medivation, Inc., Vice President-Regulatory Affairs at Peloton Therapeutics, Inc., and Vice President-Regulatory Affairs at Calithera Biosciences, Inc. She obtained her undergraduate degree from the University of California, Santa Cruz.
Actieve functies van Cheryl A. Madsen
| Bedrijven | Functie | Begin |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Algemeen Adviseur | - |
Eerdere bekende functies van Cheryl A. Madsen
| Bedrijven | Functie | Einde |
|---|---|---|
| PELOTON THERAPEUTICS, INC. | Algemeen Adviseur | - |
| Medivation, Inc. /Old/ | Corporate Officer/Principal | - |
| CALITHERA BIOSCIENCES, INC. | Algemeen Adviseur | - |
Opleiding van Cheryl A. Madsen
| University of California, Santa Cruz | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
